Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Synthesis of64Cu-,55Co-, and68Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles

Journal of Nuclear Medicine(2024)10.2967/jnumed.124.267469Source: DataRank Database

Synthesis of64Cu-,55Co-, and68Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles is a research paper published in Journal of Nuclear Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.11)OA: bronzeTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Xinrui Ma ORCID,Wilson Lin ORCID,Tao Zhang ORCID,Weiling Zhao,Liqin Pan

Live enrichment

PubMed:38871388 PMC:PMC11294072 OpenAlex:https://openalex.org/W4399623799

NCI NIH HHS

Grant: P01 CA250972

NCI NIH HHS

Grant: P30 CA014520

NCI NIH HHS

Grant: R43 CA261503

NCI NIH HHS

Grant: R01 CA247769

NIH HHS

Grant: S10 OD023611

NCI NIH HHS

Grant: P30 CA016086

FWCI

2.11

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

bronze

journalhttps://jnm.snmjournals.org/content/jnumed/early/2024/06/13/jnumed.124.267469.full.pdf

publisherhttps://jnm.snmjournals.org/content/jnumed/early/2024/06/13/jnumed.124.267469.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.2967/jnumed.124.267469

journalhttps://doi.org/10.2967/jnumed.124.267469

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38871388

Fields of Study

Radiopharmaceutical Chemistry and ApplicationsNeuropeptides and Animal PhysiologyPeptidase Inhibition and AnalysisReceptors, NeurotensinCopper RadioisotopesAnimalsMiceRadiopharmaceuticalsTissue DistributionHumansGallium RadioisotopesMacrocyclic CompoundsIsotope LabelingCell Line, TumorAminesPrecision MedicineRadiochemistryChemistry Techniques, SyntheticPositron Emission Tomography Computed Tomography

MeSH Terms

Positron Emission Tomography Computed TomographyAminesAnimalsCopper RadioisotopesGallium RadioisotopesHumansIsotope LabelingRadiochemistryTissue DistributionReceptors, NeurotensinRadiopharmaceuticalsCell Line, TumorMacrocyclic CompoundsMicePrecision MedicineChemistry Techniques, Synthetic

Keywords

NeurotensinChemistryIn vivoInternalizationRadiochemistryDOTAChelationNeurotensin receptorNuclear chemistryReceptorBiochemistryInorganic chemistryNeuropeptidePETprostate cancer68Ga64Cu55CoRadiotheranostic Agent

Sustainable Development Goals

SDG 0: Zero hunger

Synthesis of64Cu-,55Co-, and68Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles

FAIR Checklist

Authors (15)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)